Targeting intracellular compartments by magnetic polymeric nanoparticles

European Journal of Pharmaceutical Sciences

Volumn 50, Issue 1, 2013, Pages 130-138

  Kocbek, Petra ^a   Kralj, Slavko ^b   Kreft, Mateja Erdani ^a   Kristl, Julijana ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Emulsion solvent evaporation method; Magnetic targeting; Nanoparticles; PLGA; Superparamagnetic iron oxide

Indexed keywords

FERRIC OXIDE; MAGNETIC NANOPARTICLE; RICINOLEIC ACID; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; CHEMICAL INTERACTION; CONTROLLED STUDY; INTERNALIZATION; MAGNET; MAGNETIC FIELD; POLYMERIZATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TARGET CELL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84885034791     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.04.004     Document Type: Article

References (36)

1. Acharya, S., Sahoo, S.K., 2011. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv. Drug Deliver. Rev. 63, 170-183.
2. Al-Kady, A.S., Gaber, M., Hussein, M.M., Ebeid, E.-Z.M., 2011. Structural and fluorescence quenching characterization of hematite nanoparticles. Spectrochim. Acta, Part A 83, 398-405.
3. Bae, J.-E., Huh, M.-I., Ryu, B.-K., Do, J.-Y., Jin, S.-U., Moon, M.-J., Jung, J.-C., Chang, Y., Kim, E., Chi, S.-G., Lee, G.-H., Chae, K.-S., 2011. The effect of static magnetic fields on the aggregation and cytotoxicity of magnetic nanoparticles. Biomaterials 32, 9401-9414.
4. Bootdee, K., Nithitanakul, M., Grady, B., 2012. Synthesis and encapsulation of magnetite nanoparticles in PLGA: effect of amount of PLGA on characteristics of encapsulated nanoparticles. Polym. Bull. 69, 795-806.
5. Butoescu, N., Seemayer, C.A., Foti, M., Jordan, O., Doelker, E., 2009. Dexamethasone containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis. Biomaterials 30, 1772-1780.
6. Buyukhatipoglu, K., Clyne, A.M., 2011. Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation. J. Biomed. Mater. Res. Part A 96A, 186-195.
7. Danhier, F., Ansorena, E., Silva, J.M., Coco, R., Le Breton, A., Préat, V., 2012. PLGAbased nanoparticles: an overview of biomedical applications. J. Control. Release 161, 505-522.
8. Dilnawaz, F., Singh, A., Mewar, S., Sharma, U., Jagannathan, N.R., Sahoo, S.K., 2012. The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model. Biomaterials 33, 2936-2951.
9. Furlan, M., Kluge, J., Mazzotti, M., Lattuada, M., 2010. Preparation of biocompatible magnetite-PLGA composite nanoparticles using supercritical fluid extraction of emulsions. J. Supercrit. Fluid. 54, 348-356.
10. Gyergyek, S., Makovec, D., Drofenik, M., 2011. Colloidal stability of oleic-and ricinoleic-acid-coated magnetic nanoparticles in organic solvents. J. Colloid Interface Sci. 354, 498-505.
11. 4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery. Int. J. Nanomed. 7, 1697-1708.
12. Kaminski, M.D., Xie, Y., Mertz, C.J., Finck, M.R., Chen, H., Rosengart, A.J., 2008. Encapsulation and release of plasminogen activator from biodegradable magnetic microcarriers. Eur. J. Pharm. Sci. 35, 96-103.
13. Kocbek, P., Obermajer, N., Cegnar, M., Kos, J., Kristl, J., 2007. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J. Control. Release 120, 18-26. (Pubitemid 46874614)
14. Kocbek, P., Teskač, K., Kreft, M.E., Kristl, J., 2010. Toxicological aspects of long-term treatment of keratinocytes with ZnO and TiO2 nanoparticles. Small 6, 1908-1917.
15. Kralj, S., Drofenik, M., Makovec, D., 2011. Controlled surface functionalization of silica-coated magnetic nanoparticles with terminal amino and carboxyl groups. J. Nanopart. Res. 13, 2829-2841.
16. Lerch, S., Dass, M., Musyanovych, A., Landfester, K., Mailänder, V., 2013. Polymeric nanoparticles of different sizes overcome the cell membrane barrier. Eur. J. Pharm. Biopharm. http://dx.doi.org/10.1016/j.ejpb.2013.01.024.
17. 4 magnetic nanoparticles for targeted anticancer effects. Eur. J. Pharm. Sci. 48, 111-120.
18. Liu, X., Kaminski, M.D., Chen, H., Torno, M., Taylor, L., Rosengart, A.J., 2007. Synthesis and characterization of highly-magnetic biodegradable poly(d, l-lactide-coglycolide) nanospheres. J. Control. Release 119, 52-58. (Pubitemid 46561544)
19. Mahmoudi, M., Sant, S., Wang, B., Laurent, S., Sen, T., 2011. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv. Drug Deliver. Rev. 63, 24-46.
20. McBain, S.C., Yiu, H.H., Dobson, J., 2008. Magnetic nanoparticles for gene and drug delivery. Int. J. Nanomed. 2, 169-180. (Pubitemid 352037850)
21. Müller, R.H., Maaßen, S., Weyhers, H., Specht, F., Lucks, J.S., 1996. Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int. J. Pharm. 138, 85-94. (Pubitemid 26241925)
22. Ngaboni Okassa, L., Marchais, H., Douziech-Eyrolles, L., Cohen-Jonathan, S., Soucé, M., Dubois, P., Chourpa, I., 2005. Development and characterization of submicron poly(d, l-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles. Int. J. Pharm. 302, 187-196. (Pubitemid 41242763)
23. Oh, J.K., Park, J.M., 2011. Iron oxide-based superparamagnetic polymeric nanomaterials: design, preparation, and biomedical application. Prog. Polym. Sci. 36, 168-189.
24. Okassa, L.N., Marchais, H., Douziech-Eyrolles, L., Hervé, K., Cohen-Jonathan, S., Munnier, E., Soucé, M., Linassier, C., Dubois, P., Chourpa, I., 2007. Optimization of iron oxide nanoparticles encapsulation within poly(d, l-lactide-co-glycolide) sub-micron particles. Eur. J. Pharm. Biopharm. 67, 31-38. (Pubitemid 46991326)
25. Pankhurst, Q.A., Connolly, J., Jones, S.K., Dobson, J., 2003. Applications of magnetic nanoparticles in biomedicine. J. Phys. D: Appl. Phys. 36, R167.
26. Park, J., Yang, J., Lee, J., Lim, E.-K., Suh, J.-S., Huh, Y.-M., Haam, S., 2009. Synthesis and characterization of fluorescent magneto polymeric nanoparticles (FMPNs) for bimodal imaging probes. J. Colloid Interface Sci. 340, 176-181.
27. Pérez-Artacho, B., Gallardo, V., Ruiz, M.A., Arias, J., 2012. Maghemite/poly(d, llactide-co-glycolyde) composite nanoplatform for therapeutic applications. J. Nanopart. Res. 14, 1-10.
28. Petri-Fink, A., Steitz, B., Finka, A., Salaklang, J., Hofmann, H., 2008. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): Colloidal stability, cytotoxicity, and cellular uptake studies. Eur. J. Pharm. Biopharm. 68, 129-137. (Pubitemid 350181416)
29. Rojnik, M., Kocbek, P., Moret, F., Compagnin, C., Celotti, L., Bovis, M.J., Woodhams, J.H., MacRobert, A.J., Scheglmann, D., Helfrich, W., Verkaik, M.J., Papini, E., Reddi, E., Kos, J., 2012. In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy. Nanomedicine 7, 663-677.
30. Shi, S.-f., Jia, J.-f., Guo, X.-k., Zhao, Y.-p., Liu, B.-y., Chen, D.-s., Guo, Y.-y., Zhang, X.-l., 2012. Toxicity of iron oxide nanoparticles against osteoblasts. J. Nanopart. Res. 14, 1-11.
31. Singh, N., Jenkins, G.J.S., Nelson, B.C., Marquis, B.J., Maffeis, T.G.G., Brown, A.P., Williams, P.M., Wright, C.J., Doak, S.H., 2012. The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles. Biomaterials 33, 163-170.
32. Skouras, A., Mourtas, S., Markoutsa, E., De Goltstein, M.-C., Wallon, C., Catoen, S., Antimisiaris, S.G., 2011. Magnetoliposomes with high USPIO entrapping efficiency, stability and magnetic properties. Nanomed.: Nanotech. Biol. Med. 7, 572-579.
33. Soenen, S.J.H., Himmelreich, U., Nuytten, N., De Cuyper, M., 2011. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 32, 195-205.
34. Tietze, R., Lyer, S., Dürr, S., Alexiou, C., 2012. Nanoparticles for cancer therapy using magnetic forces. Nanomedicine 7, 447-457.
35. Wassel, R.A., Grady, B., Kopke, R.D., Dormer, K.J., 2007. Dispersion of super paramagnetic iron oxide nanoparticles in poly(d, l-lactide-co-glycolide) microparticles. Colloid. Surf. A 292, 125-130. (Pubitemid 44918304)
36. Zhou, J., Leuschner, C., Kumar, C., Hormes, J.F., Soboyejo, W.O., 2006. Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases. Biomaterials 27, 2001-2008. (Pubitemid 41759493)